The Journal of Immunology, Vol 148, Issue 3 888-893, Copyright © 1992 by American Association of Immunologists

ARTICLES

Epitopes of group A streptococcal M protein that evoke cross-protective local immune responses

MS Bronze, HS Courtney and JB Dale
Department of Veterans Affairs Medical Center, Memphis, TN 38104.

The present studies were undertaken to identify conserved epitopes of group A streptococcal M proteins that evoke cross-protective mucosal immune responses. Two synthetic peptides copying conserved regions of type 5 M protein, designated SM5(235-264)C and SM5(265-291)C, were covalently linked to carrier molecules and their immunogenicity was tested in laboratory animals. Rabbit antisera against both peptides cross-reacted with multiple serotypes of group A streptococci, indicating that the peptides contained broadly cross-reactive, surface exposed M protein epitopes. Serum antipeptide antibodies adsorbed to the surface of heterologous type 24 streptococci passively protected mice against intranasal challenge infections. Mice that were actively immunized intranasally with each synthetic peptide covalently linked to the B subunit of cholera toxin were protected against colonization and death after intranasal challenge infections with type 24 streptococci in the absence of serum opsonic antibodies. These data confirm and extend previous observations that conserved M protein epitopes evoke cross-protective local immunity and may serve as the basis for broadly cross-protective M protein vaccines.

This article has been cited by other articles:

				M. A. Hall, S. D. Stroop, M. C. Hu, M. A. Walls, M. A. Reddish, D. S. Burt, G. H. Lowell, and J. B. Dale Intranasal Immunization with Multivalent Group A Streptococcal Vaccines Protects Mice against Intranasal Challenge Infections Infect. Immun., May 1, 2004; 72(5): 2507 - 2512. [Abstract] [Full Text] [PDF]

				H. S. Courtney, D. L. Hasty, and J. B. Dale Serum Opacity Factor (SOF) of Streptococcus pyogenes Evokes Antibodies That Opsonize Homologous and Heterologous SOF-Positive Serotypes of Group A Streptococci Infect. Immun., September 1, 2003; 71(9): 5097 - 5103. [Abstract] [Full Text] [PDF]

				C. Olive, M. Batzloff, A. Horvath, T. Clair, P. Yarwood, I. Toth, and M. F. Good Potential of Lipid Core Peptide Technology as a Novel Self-Adjuvanting Vaccine Delivery System for Multiple Different Synthetic Peptide Immunogens Infect. Immun., May 1, 2003; 71(5): 2373 - 2383. [Abstract] [Full Text] [PDF]

				C. Olive, M. R. Batzloff, A. Horvath, A. Wong, T. Clair, P. Yarwood, I. Toth, and M. F. Good A Lipid Core Peptide Construct Containing a Conserved Region Determinant of the Group A Streptococcal M Protein Elicits Heterologous Opsonic Antibodies Infect. Immun., May 1, 2002; 70(5): 2734 - 2738. [Abstract] [Full Text] [PDF]

				K. F. Jones, S. S. Whitehead, M. W. Cunningham, and V. A. Fischetti Reactivity of Rheumatic Fever and Scarlet Fever Patients' Sera with Group A Streptococcal M Protein, Cardiac Myosin, and Cardiac Tropomyosin: a Retrospective Study Infect. Immun., December 1, 2000; 68(12): 7132 - 7136. [Abstract] [Full Text] [PDF]

				M. W. Cunningham Pathogenesis of Group A Streptococcal Infections Clin. Microbiol. Rev., July 1, 2000; 13(3): 470 - 511. [Abstract] [Full Text] [PDF]

				E. R. Brandt, W. A. Hayman, B. Currie, J. Carapetis, D. C. Jackson, K.-A. Do, and M. F. Good Functional analysis of IgA antibodies specific for a conserved epitope within the M protein of group A streptococci from Australian Aboriginal endemic communities Int. Immunol., April 1, 1999; 11(4): 569 - 576. [Abstract] [Full Text] [PDF]

				A. Quinn, K. Ward, V. A. Fischetti, M. Hemric, and M. W. Cunningham Immunological Relationship between the Class I Epitope of Streptococcal M Protein and Myosin Infect. Immun., September 1, 1998; 66(9): 4418 - 4424. [Abstract] [Full Text] [PDF]